Ribosomal protein L7a pseudogene 17 (RPL7AP17)

Ribosomal protein L7a pseudogene 17 (RPL7AP17) is a processed pseudogene derived from the ribosomal protein L7a gene (RPL7A). Pseudogenes like RPL7AP17 arise from gene duplication or retrotransposition events and are usually non-functional: they are not transcribed into functional proteins and do not serve a biological role. RPL7AP17 is listed in gene product registries as a pseudogene, not a protein-coding gene, and has no direct functional, disease, or drug relevance. The parental RPL7A gene is a component of the 60S ribosomal subunit with established biological roles, but the pseudogene RPL7AP17 does not share those roles or importance[1][4][6]. Key clarifications: - RPL7AP17 is not a gene product, receptor, enzyme, or therapeutic target, but a pseudogene without current biological or pharmacological relevance[4][6]. - There is no evidence for disease association, drug interaction, or use as a biomarker. - Its only function is as a processed genomic remnant from the RPL7A gene. Summary: RPL7AP17, or ribosomal protein L7a pseudogene 17, is a non-coding human pseudogene, not a therapeutic target, and lacks functional roles, disease association, or pharmacological importance. The entry is likely incorrect as a therapeutic target[4][6].

Other names

RPL7A_3_78RPL7AP17